Erlotinib Completed Phase 2 Trials for Mesothelioma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00137826Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma